explore -WSS

explore

author：fashion 2025-09-27 18:53:40 - browse：53

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Kellogg’s is going to war over Mexico’s nutrition label rules

WSS

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Vivek Ramaswamy made waves in the debate, much as in biotech

Custom gene therapy hints at new path for rare disease treatments

FDA greenlights medical device to combat bladder issues

People can get long Covid without testing positive for virus: Study

Roche's accidental data boosts hopes for anti

explore

explore

Wikipedia

Cancer drug shortages should be causing more outrage

Trans patients at the end of life deserve respect and dignity

Moonlake's readout produced a cash windfall. Risks remain

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Activists slam private health insurers over coverage restrictions

Startup Neumora takes a novel depression drug to Phase 3

Trump demands the U.S. pay no more for drugs than other countries … again

WHO calls for emergency meeting on new China virus, as cases spread

Apple is now the first public company to be valued at $3 trillion

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

Trans patients at the end of life deserve respect and dignity

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Key House panel plots a new health care package

Vivek Ramaswamy made waves in the debate, much as in biotech

DeSantis wants to import drugs. Biden’s FDA blasted his plan

DeSantis wants to import drugs. Biden’s FDA blasted his plan

leisure time

hotspot

knowledge

focus